An official website of the United States government
Home
Name
POCC
Alternate names
None
Primary Site
None
Histology
None
Radiation
None
Remarks
None
Drugs for POCC
Name
Alternate Names
Belustine (nitrosourea)
CeeNu
Chloroethylcyclohexylnitrosourea
ICIG 1109
RB1509
WR-139017
Abbreviations
CCNU
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
079037
79037
Primary Site
Histology
None
Remarks
Cell-cycle nonspecific antineoplastic agent;alkylating agent. FDA approved uses in brain tumor and Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Ibenzmethyzin Hydrochloride
Matulane
Methylhydrazine
N-Methylhydrazine
Natulan
Natulane
Procarbazine hydrochloride
Ro-4-6467
Ro4-6467/1
Abbreviations
IBZ
MIH
PCB
PCH
PCI
PCZ
Category
Chemotherapy
Subcategory
Nonclassic alkylating agent
NSC Number
077213
77213
Primary Site
Brain tumors adjuvant and/or advanced disease
Cutaneous T-cell lymphoma
Hodgkin lymphoma
Non-Hodgkin lymphoma
Histology
None
Remarks
An orally administered hydrazine derivative antineoplastic agent. FDA approved in stages III, IV Hodgkin's lymphoma.
Coding
This drug should be coded
Name
Alternate Names
Asta B 518
B-518
Clafen Claphene
Cyclophosphamid
Cyclophosphan
Cyclophosphane
Cytophosphan
Cytoxan
Endoxan
Endoxana
Enduxan
Genoxal
Neosar
Procytox
Sendoxan
Tymtram
WR-138719
Abbreviations
CP
CPM
CTX
CTY
CYC
Cyclo
CYT
CYTOX
CYTX
Category
Chemotherapy
Subcategory
Alkylating agent
NSC Number
026271
26271
Primary Site
Histology
None
Remarks
An effective antineoplastic agent and is used for a variety of cancers. FDA approved uses on breast cancer, ovarian carcinoma, leukemia, lymphomas, multiple myeloma, neuroblastma, retinoblastoma, soft tissue sarcoma, Wilm's tumor. Alkylating agent
Coding
This drug should be coded
Name
Alternate Names
Compound 37231
Leurocristine Sulfate
Oncovin
Vincasar
Vincasar PFS
Vincristine Sulfate
Vincrystine
Vinkristin
Abbreviations
LCR
VCR
VNCR
Category
Chemotherapy
Subcategory
Plant alkyloid--antimetabolite
NSC Number
067574
67574
Primary Site
None
Histology
None
Remarks
Antineoplastic; vinca plant alkaloid; antimetabolite. FDA approved uses in ALL, Hodgkin's lymphoma, non-Hodgkin's lymphoma, neuroblastoma, rhabomyosarcoma, and Wilm's tumor.
Coding
This drug should be coded
